Research Update - June 2022

There are exciting things ahead with the upcoming launch of our new 5-year strategy and a growing research team Read more

Research Update - March 2022

In 2022 we are aiming to improve and increase patient representation in neuroblastoma research. This spotlight on research advocacy explains exactly what that means and how we will achieve it. Read more

Relapse Prevention Therapies: an in-depth look

In this special edition of our research blog, Research Director and Chair of Trustees Nick Bird looks at the landscape of maintenance therapies and their accessibility in the UK. Read more

Neuroblastoma Parent Global Symposium 2021- A round-up

Read the highlights of our second virtual parent conference hosted with Solving Kids' Cancer Us and the Children's Neuroblastoma Cancer Foundation Read more

Research Update - December 2021

Heading into Winter, we have lots of exciting updates from the Research team at Solving Kids' Cancer Read more

Behind the Research: Felix's Incredible Legacy

After losing his battle with neuroblastoma aged 6, Felix left an incredible legacy which will help countless children just like him. Read more

Research Update- September 2021

The summer months are always busy here for team SKC with lots of exciting things around the corner in Autumn to prepare for. Read more

Research Explainer: How do ALK gene alterations affect the clinical outcome for patients with high-risk neuroblastoma?

Find out more about the latest breakthrough from researchers across Europe on the significance of ALK gene alterations in high-risk neuroblastoma. Read more

An AMRC Member Charity: What does it mean?

In 2018, we announced our awarded membership to the Association of Medical Research Charities (AMRC), but what does this actually mean for our research? Read more

Research Update - June 2021

The Spring months have been as busy as ever for our research team, with the announcement of our latest project as well as progress reviews for our ongoing work and looking ahead at the SKC research strategy for the coming years. Read more

Exploring the Statistics Behind Neuroblastoma in the UK

A closer look into the National Cancer Registration and Analysis Service (NCRAS) 2021 report on cancer in children, teenagers and young adults. Read more

Research Explainer: Single Cell Study Finds Sympathoblasts as the Root of Neuroblastoma

Last month, researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital and Princess Máxima Centre published a new single cell study that has shown all neuroblastomas arise from one type of developmental cell called sympathoblasts. We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients. Read more